Selling and other commercial expenses
Vertex Pharmaceuticals·Business Segments·1 segment
Breakdown
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|
| Pharmaceuticals | $241.1M | $264.6M | $278.3M | $318.8M |
| Total | $241.1M | $264.6M | $278.3M | $318.8M |
Segments
PharmaceuticalsView metric